Early Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth Factor-Experienced Patients with Neovascular Age-Related Macular Degeneration: A Retrospective Chart Review

Early Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth Factor-Experienced Patients with Neovascular Age-Related Macular Degeneration: A Retrospective Chart Review

Michel Giunta,1,2 Louis-Pierre Gauvin Meunier,3 Donald Nixon,4,5 Jeff Steeves,6 Jason Noble7,8 1GOGiunta Ophtalmologie, Sherbrooke, QC, Canada; 2Department of Surgery, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada; 3Institut de l’Œil des Laurentides, Boisbriand, QC, Canada;...

Full description

Bibliographic Details
Main Authors: Giunta M, Gauvin Meunier LP, Nixon D, Steeves J, Noble J
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Clinical Ophthalmology
Subjects:
best-corrected visual acuity
central retinal thickness
injection interval
intraocular inflammation
retinal vascular occlusion
Online Access:https://www.dovepress.com/early-canadian-real-world-experience-with-brolucizumab-in-anti-vascula-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/early-canadian-real-world-experience-with-brolucizumab-in-anti-vascula-peer-reviewed-fulltext-article-OPTH

Similar Items